EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Diffuse large B-cell lymphoma complicated by cytokine release syndrome and immune effector cell–associated neurotoxicity on day 355 of epcoritamab therapy: a case report

Yasunobu Sekiguchi, Kosuke Arai, Shizuka Hamano, Masahisa Kudo, Nobuo Maseki, Yoshie Iizaki, Machiko Kawamura, Kazuhiko Kobayashi, Yu Nishimura, Hiroaki Kanda, Daisuke Takei, Tomoya Abe und 5 weitere

Journal of Clinical and Experimental Hematopathology · 2026 · 66 (2) · 177-181

DOI: 10.3960/jslrt.26004 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2026. Verfasst von Yasunobu Sekiguchi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

100 mg/body), which resulted in complete remission (CR 1) (Figure 1b). However, the illness recurred in February Year X-4. The patient was subsequently treated with six courses of R-MECP therapy (rituximab 375 mg/m 2 , carboplatin 300 mg/ m 2 , etoposide 70 mg/m 2 , mitoxantrone 8 mg/m 2 , and prednisone 40 mg/m 2 ), which again resulted in CR (CR 2). The illness recurred once more in March Year X-2, and the patient received six courses of PBR therapy (polatuzumab vedotin 1.8 mg/kg, bendamustine 90 mg/m 2 , and rituximab 375 mg/m 2 ), which led to CR 3. The lymphocyte count was 3720/μL immediately before the start of PBR therapy and decreased to 90/μL by its completion. In November Year X-1, the illness recurred again (Figure 1c), and by December, epcoritamab was initiated (following a bendamustine washout period of 15.5

Schlagwörter

Stichwörter der Autor:innen

bispecific antibodiescytokine release syndromeepcoritamabimmune effector cell–associated neurotoxicity syndromelate onset

Autor:innen und Institutionen

  • Department of Hematology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
  • Department of Clinical Laboratory Medicine, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
  • Department of Inspection Engineering, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
  • Department of Pathology, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
  • Department of pharmacy, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.
  • Department of Radiation therapy, Saitama Cancer Center, Kita-adachi-gun, Saitama, Japan.

Zitieren

APA

Sekiguchi, Y., Arai, K., Hamano, S., Kudo, M., Maseki, N., Iizaki, Y., Kawamura, M., Kobayashi, K., Nishimura, Y., Kanda, H., Takei, D., Abe, T., Hanai, M., Endo, S., Nakayama, T., Shimano, Y., & Kobayashi, H. (2026). Diffuse large B-cell lymphoma complicated by cytokine release syndrome and immune effector cell–associated neurotoxicity on day 355 of epcoritamab therapy: a case report. Journal of Clinical and Experimental Hematopathology, 66(2), 177-181. https://doi.org/10.3960/jslrt.26004

Vancouver

Sekiguchi Y, Arai K, Hamano S, Kudo M, Maseki N, Iizaki Y, et al. Diffuse large B-cell lymphoma complicated by cytokine release syndrome and immune effector cell–associated neurotoxicity on day 355 of epcoritamab therapy: a case report. Journal of Clinical and Experimental Hematopathology. 2026;66(2):177-181. doi:10.3960/jslrt.26004

BibTeX
@article{Sekiguchi2026,
  author = {Sekiguchi, Yasunobu and Arai, Kosuke and Hamano, Shizuka and Kudo, Masahisa and Maseki, Nobuo and Iizaki, Yoshie and Kawamura, Machiko and Kobayashi, Kazuhiko and Nishimura, Yu and Kanda, Hiroaki and Takei, Daisuke and Abe, Tomoya and Hanai, Makoto and Endo, Sayaka and Nakayama, Toshiaki and Shimano, Yasumasa and Kobayashi, Hirofumi},
  title = {Diffuse large B-cell lymphoma complicated by cytokine release syndrome and immune effector cell–associated neurotoxicity on day 355 of epcoritamab therapy: a case report},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2026},
  volume = {66},
  number = {2},
  pages = {177--181},
  doi = {10.3960/jslrt.26004}
}
Kostenlos starten →